Difference between revisions of "Team:Aalto-Helsinki/Story"
| Line 30: | Line 30: | ||
<p id="paragraph"> | <p id="paragraph"> | ||
| − | It was clear from the very first group meeting we had as Aalto-Helsinki team we wanted to make a difference and solve big global problems. Maybe we were a bit humble in front of the possibilities we had but we were brave. We had many ideation meetings and had many brilliant ideas, concepts and things to solve, but every time we ended up with one particular problem – Antimicrobial resistance | + | It was clear from the very first group meeting we had as Aalto-Helsinki team we wanted to make a difference and solve big global problems. Maybe we were a bit humble in front of the possibilities we had but we were brave. We had many ideation meetings and had many brilliant ideas, concepts and things to solve, but every time we ended up with one particular problem – Antimicrobial resistance towards the commonly used antibiotics. Antimicrobial resistance is one of the biggest challenges of today. We were wondering how we could ease the problem even a bit. |
| − | We started by going through many research papers and projects already done in iGEM and research groups. And then suddenly we found one interesting paper and were introduced with dermcidin, a peptide that exist inside human body and sweat. A peptide with antimicrobial features and strength to fight against some specific bacteria. A peptide which has been in front of our eyes all the time, in our hands, arms | + | We started by going through many research papers and projects already done in iGEM and research groups. And then suddenly we found one interesting paper and were introduced with dermcidin, a peptide that exist inside human body and sweat. A peptide with antimicrobial features and strength to fight against some specific bacteria. A peptide which has been in front of our eyes all the time, in our hands, arms, foreheads while we were stressing and sweating with the ideation and brainstorming. |
</p> | </p> | ||
| Line 37: | Line 37: | ||
<p id="paragraph"> | <p id="paragraph"> | ||
| − | As a healthy group of people we all thought that sweating is good and if by sweating we could fight against harmful bacteria, it must be great start for iGEM project, so we were thrilled with | + | As a healthy group of people we all thought that sweating is good and if by sweating we could fight against harmful bacteria, it must be a great start for an iGEM project, so we were thrilled with dermcidin and started to work with that. |
| − | We learned it has | + | We learned it has been observed to be resistant against some of the most common hospital bacteria and also against acne causing bacteria. These both paths, hospital acquired infections and acne, were calling us and we had lots of ideas and meetings regarding both of them. |
</p> | </p> | ||
| Line 45: | Line 45: | ||
<p id="paragraph"> | <p id="paragraph"> | ||
| − | In hospitals it could be used for wound care as a dressing, bandage or other kind of | + | In hospitals it could be used for wound care as a dressing, bandage or other kind of disinfecting treatment. We even designed special cellulose binding domain and added it into our E.coli construct to be produced with dermcidin, so we could create a strong link between it and cellulose-based materials used in wound dressings. We interviewed many specialists, doctors, patients and even medical companies, and started to design the application for wound care, an area that we thought would need improvements. We knew the potential of our application idea and we knew there would be a market space for it, but something made us question whether we should work on wound care, coating or hospital acquired infections after all. We realized we couldn’t reach that many people with this topic and tell them about the possibilities of synthetic biology. Our need and desire for real conversation with the general public turned out to be more important than a new promising application in the hospital environment so we ended up doing what you never should do in the middle of the project – we changed our direction. |
| − | Synthetic biology is poorly known among | + | Synthetic biology is poorly known among most people in Finland. Most of the population knows something about GMO, maybe mainly something very negative comes to their minds, but it doesn’t matter who you ask outside of the field of biology, almost no one is able to talk about synthetic biology. |
So with our application design we wanted to focus on something that normal people can easily identify themselves with, common illness that 80-90% of the world population is suffering at some point in their lives, acne. | So with our application design we wanted to focus on something that normal people can easily identify themselves with, common illness that 80-90% of the world population is suffering at some point in their lives, acne. | ||
</p> | </p> | ||
| Line 54: | Line 54: | ||
<p id="paragraph"> | <p id="paragraph"> | ||
That made a difference. It was surprising how easy it was to collect stories from people who have had acne and experts who have been working with the topic. In one week we got over 100 responses to our acne survey. In the end we got almost 200 responses. And to be clear, in Finland that rarely happens. | That made a difference. It was surprising how easy it was to collect stories from people who have had acne and experts who have been working with the topic. In one week we got over 100 responses to our acne survey. In the end we got almost 200 responses. And to be clear, in Finland that rarely happens. | ||
| − | It was touching how openly people shared their stories and struggles with acne and how in so many levels it affects people’s lives such | + | It was touching how openly people shared their stories and struggles with acne and how in so many levels it affects people’s lives for such long times. We were also frustrated while talking with a dermatologist who told us there haven't been much research done about acne in the past 30 years, even though it is so common all around the world. We found so many rumors, poor self-treatment advises, stories about horrible side effects caused by strong medicines and all kinds of fallacies about acne so we got really interested whether we could tackle it with science. We got the feeling we are working with something that matters. |
| − | We were encouraged because of the stories of | + | We were encouraged because of the stories of people and decided to create a concept of an antimicrobial skin care product that could possibly be an alternative for treating acne with antibiotics or other medicines. The only purpose of this concept is not to wrap our research and work done in a lab together but also spread the word about acne, synthetic biology and the possibilities it brings. |
</p> | </p> | ||
Revision as of 14:24, 28 October 2017
Story
It was clear from the very first group meeting we had as Aalto-Helsinki team we wanted to make a difference and solve big global problems. Maybe we were a bit humble in front of the possibilities we had but we were brave. We had many ideation meetings and had many brilliant ideas, concepts and things to solve, but every time we ended up with one particular problem – Antimicrobial resistance towards the commonly used antibiotics. Antimicrobial resistance is one of the biggest challenges of today. We were wondering how we could ease the problem even a bit. We started by going through many research papers and projects already done in iGEM and research groups. And then suddenly we found one interesting paper and were introduced with dermcidin, a peptide that exist inside human body and sweat. A peptide with antimicrobial features and strength to fight against some specific bacteria. A peptide which has been in front of our eyes all the time, in our hands, arms, foreheads while we were stressing and sweating with the ideation and brainstorming.
As a healthy group of people we all thought that sweating is good and if by sweating we could fight against harmful bacteria, it must be a great start for an iGEM project, so we were thrilled with dermcidin and started to work with that. We learned it has been observed to be resistant against some of the most common hospital bacteria and also against acne causing bacteria. These both paths, hospital acquired infections and acne, were calling us and we had lots of ideas and meetings regarding both of them.
In hospitals it could be used for wound care as a dressing, bandage or other kind of disinfecting treatment. We even designed special cellulose binding domain and added it into our E.coli construct to be produced with dermcidin, so we could create a strong link between it and cellulose-based materials used in wound dressings. We interviewed many specialists, doctors, patients and even medical companies, and started to design the application for wound care, an area that we thought would need improvements. We knew the potential of our application idea and we knew there would be a market space for it, but something made us question whether we should work on wound care, coating or hospital acquired infections after all. We realized we couldn’t reach that many people with this topic and tell them about the possibilities of synthetic biology. Our need and desire for real conversation with the general public turned out to be more important than a new promising application in the hospital environment so we ended up doing what you never should do in the middle of the project – we changed our direction. Synthetic biology is poorly known among most people in Finland. Most of the population knows something about GMO, maybe mainly something very negative comes to their minds, but it doesn’t matter who you ask outside of the field of biology, almost no one is able to talk about synthetic biology. So with our application design we wanted to focus on something that normal people can easily identify themselves with, common illness that 80-90% of the world population is suffering at some point in their lives, acne.
That made a difference. It was surprising how easy it was to collect stories from people who have had acne and experts who have been working with the topic. In one week we got over 100 responses to our acne survey. In the end we got almost 200 responses. And to be clear, in Finland that rarely happens. It was touching how openly people shared their stories and struggles with acne and how in so many levels it affects people’s lives for such long times. We were also frustrated while talking with a dermatologist who told us there haven't been much research done about acne in the past 30 years, even though it is so common all around the world. We found so many rumors, poor self-treatment advises, stories about horrible side effects caused by strong medicines and all kinds of fallacies about acne so we got really interested whether we could tackle it with science. We got the feeling we are working with something that matters. We were encouraged because of the stories of people and decided to create a concept of an antimicrobial skin care product that could possibly be an alternative for treating acne with antibiotics or other medicines. The only purpose of this concept is not to wrap our research and work done in a lab together but also spread the word about acne, synthetic biology and the possibilities it brings.
References
[1] Writers, YEAR. Name of article / book. Publication. Accessible at: [url here].
[2] Writers, YEAR. Name of article / book. Publication. Accessible at: [url here].
[3] Writers, YEAR. Name of article / book. Publication. Accessible at: [url here].
[4] Writers, YEAR. Name of article / book. Publication. Accessible at: [url here].
[5] Writers, YEAR. Name of article / book. Publication. Accessible at: [url here].
